About 84 per cent IT employees in India have fatty liver disease while around 71 per cent are obese, says a study ...

A simple urine test could accurately detect recurring kidney cancer in patients recovering from surgery for the disease, potentially sparing them from frequent follow-up scans, researchers suggest.The ...

China: A new study published in the International Journal of General Medicine highlighted the potential role of serum cholinesterase (ChE) levels as a biomarker for assessing prognosis in ovarian ...

The need to address disparities in cancer screening rates is an oft-discussed issue in healthcare. Strategies on how to address the issue are less straightforward, leaving many leaders searching for ...

After battling stage 3 colorectal cancer, Ashlee and Ray Hall use their experience to support others by hosting a 12-hour mountain bike race, "12 Hours of Twisted Oak." ...

After canceling a planned advisory committee meeting, the FDA has approved Exelixis’ Cabometyx for neuroendocrine tumors. | The FDA has approved Exelixis’ Cabometyx for neuroendocrine tumors. In an ...

If you’ve got an appetite for good food and for giving back to the community, we’ve got good news: stopping by a local Jersey Mike’s Subs for lunch or dinner today can help you satisfy both!

Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...

ALTON - Alton Memorial Health Services Foundation helps support patients with cancer by removing barriers to treatment, ...

Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus ...

This is one of the Business Journal's Best Real Estate Deals of 2024. Click the link to read about the other winning projects ...

Everything we do, we do for our B+ Heroes,” is not only a phrase that fills the halls of Jake Nevin on the day of NOVAdance, but serves as a constant reminder of NOVAdance’s purpose throughout the ...